Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guihong Wan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Investigative Dermatology|May 28, 2023
A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo NodularisChirag Vasavda, Guihong Wan, Mindy D Szeto, et al.
Medrxiv : the Preprint Server for Health Sciences|September 11, 2023
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort StudyGuihong Wan, Nga Nguyen, Bonnie W Leung, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort studyShijia Zhang, Kimberly Tang, Guihong Wan, et al.
Journal of the American Academy of Dermatology|February 3, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort studyShijia Zhang, Kimberly Tang, Guihong Wan, et al.
Clinical and Translational Medicine|November 22, 2023
Mitochondrial and immune response dysregulation in melanoma recurrenceLeticia Szadai, Jéssica de Siqueira Guedes, Nicole Woldmar, et al.
Journal of the American Academy of Dermatology|October 5, 2023
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanomaGuihong Wan, Bonnie W Leung, Mia S DeSimone, et al.
NPJ Precision Oncology|November 1, 2022
Prediction of early-stage melanoma recurrence using clinical and histopathologic featuresGuihong Wan, Nga Nguyen, Feng Liu, et al.
Journal of the American Academy of Dermatology|February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapyNga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Nature Medicine|December 16, 2022
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Sarah Abou Alaiwi, Wenxin Xu, et al.
Clinical and Translational Medicine|July 20, 2024
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanomaNatália Pinto de Almeida, Ágnes Judit Jánosi, Runyu Hong, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Investigative Dermatology|May 28, 2023
A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo NodularisChirag Vasavda, Guihong Wan, Mindy D Szeto, et al.
Medrxiv : the Preprint Server for Health Sciences|September 11, 2023
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort StudyGuihong Wan, Nga Nguyen, Bonnie W Leung, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort studyShijia Zhang, Kimberly Tang, Guihong Wan, et al.
Journal of the American Academy of Dermatology|February 3, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort studyShijia Zhang, Kimberly Tang, Guihong Wan, et al.
Clinical and Translational Medicine|November 22, 2023
Mitochondrial and immune response dysregulation in melanoma recurrenceLeticia Szadai, Jéssica de Siqueira Guedes, Nicole Woldmar, et al.
Journal of the American Academy of Dermatology|October 5, 2023
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanomaGuihong Wan, Bonnie W Leung, Mia S DeSimone, et al.
NPJ Precision Oncology|November 1, 2022
Prediction of early-stage melanoma recurrence using clinical and histopathologic featuresGuihong Wan, Nga Nguyen, Feng Liu, et al.
Journal of the American Academy of Dermatology|February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapyNga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Nature Medicine|December 16, 2022
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Sarah Abou Alaiwi, Wenxin Xu, et al.
Clinical and Translational Medicine|July 20, 2024
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanomaNatália Pinto de Almeida, Ágnes Judit Jánosi, Runyu Hong, et al.
Pageof 4